Medical University of Innsbruck·Pharmaceutical Sciences
This Master's program covers the critical aspects of drug development and the regulatory framework guiding the pharmaceutical industry. It combines theoretical knowledge with practical training to ensure graduates can navigate the complexities of drug development processes. Career prospects include positions in pharmaceutical companies, regulatory agencies, or research institutions.
No tuition
EU/EEA students at public universities, within the standard study period.
€1,453 / year
Non-EU rate — typically €726.72 per semester at public universities. Always confirm on the official site.
Third-country (non-EU/EEA) applicants generally need to have their prior qualifications legalised and translated for the admission application. Exact rules depend on the country that issued each document — always confirm with the university's admissions office.
Program-specific items — a CV, letter of motivation, an entrance exam (e.g. GMAT, GRE, SAT) or a portfolio — vary by degree. Check this program's requirements above and its official page.
The level of legalisation your certificates need depends on your country of origin:
Apostille
If your country is part of the Hague Apostille Convention, an Apostille from the competent authority of the issuing country is sufficient.
No legalisation
A small number of countries have a bilateral agreement with Austria and need no further legalisation.
Full diplomatic legalisation
For all other countries: the full chain — pre-certification by the issuing country's authorities (e.g. Ministry of Education and Ministry of Foreign Affairs), then legalisation by the competent Austrian representation (embassy/consulate).
Translations are usually done after legalisation. Check the required order with the issuing authorities and the Austrian representation.
After admission: proof of sufficient funds, health insurance and the student residence permit are part of the visa process — not university admission. We cover those in the guides.